)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Intellego Technologies
Intellego Technologies (INT) investor relations material
Intellego Technologies has been delisted
Intellego Technologies Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary20 Feb, 2026
Executive summary
Q4 2025 report and restated accounts for 2024 and 2025 were presented following extensive forensic and internal investigations into massive fraud, resulting in significant restatements and a much smaller business profile.
The outgoing board has not made binding strategic decisions, leaving a clean slate for the incoming board to determine future direction.
Stabilization efforts since November 2025 focused on understanding and addressing the fraud, restating accounts, and engaging stakeholders.
The business now centers on Daro Group, with a focus on UV disinfection and curing technologies.
2025 was marked by the arrest of the former CEO for gross fraud, leading to a forensic investigation and major restatements of financials for 2024 and 2025.
Financial highlights
SEK 640 million in 2025 and SEK 134 million in 2024 were reversed due to incorrect revenue recognition, following KPMG forensic analysis.
Group Q4 2025 revenues were SEK 25.6 million, up from SEK 21.2 million in Q4 2024; full-year 2025 group revenues were SEK 98 million, up from SEK 94 million.
Group Q4 2025 operating profit was -SEK 88 million, compared to -SEK 15 million in Q4 2024; full-year 2025 group operating profit was -SEK 175 million.
Daro Group revenue grew to GBP 7.3 million (SEK 96.1 million) in 2025, up 7.2% year-over-year, with EBITDA margin rising to 11%.
Net loss for 2025 was SEK -189.4 million, with EPS of SEK -6.16; cash flow from operating activities was SEK 55 million.
Outlook and guidance
No financial guidance for 2026 is provided; a revised business plan is in development.
The company aims to grow Daro Group with improved margins and focus on dosimeter technology for healthcare and industrial UV validation.
Emphasis on leveraging Daro as a base, with global potential for UVC products and industrial curing markets.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Intellego Technologies
- SEK 640 million in 2025 revenue was fabricated with manipulated orders and no deliveries.INT
Investor update - Q3 sales up 295% and EBIT margin at 58%, with strong global disinfection demand.INTQ3 2025
- Q2 saw strong growth, high margins, and a robust cash position, with global expansion ongoing.INTInvestor update
- Q2 2025 saw record sales and profit, with 2025 targets raised amid accelerating global growth.INTQ2 2025
- Q3 revenue up 71% year-over-year; major projects and partnerships to drive future growth.INTQ3 2024
- Record sales, profit, and cash flow in H1 2024, with strong outlook and ongoing expansion.INTQ2 2024
- Record Q1 growth and raised 2025 targets highlight Intellego's accelerating momentum.INTQ1 2025
- Strong 2024 growth, robust liquidity, and major partnerships position Intellego for 2025 expansion.INTQ4 2024
Intellego Technologies
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Intellego Technologies is a Sweden-based company specializing in photochromatic indicator technology. It is recognized as a leading manufacturer of colorimetric ultraviolet indicators, utilizing patented technology to produce devices that are crucial in validating the efficacy of ultraviolet irradiation for germicidal purposes. These indicators change color to provide visible evidence of UV-C spectrum irradiation, serving a vital role in ensuring environmental cleanliness and safety. Intellego's products find applications across diverse sectors, including healthcare, hospitality, retail, transportation, and commercial settings. Their UVC Dosimeters, in particular, are designed for various uses, from ensuring precise UV exposure levels in UV curing processes to aiding in sustainable horticulture practices. Intellego Technologies aims to lead in the development and validation of UV technology, enhancing its effectiveness for end-users worldwide. The company is headquartered in Stockholm, Sweden, and its shares are listed on Nasdaq First North.